Related Experiment Video
Updated: May 26, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
High prevalence of hepatitis B virus infection in HIV-negative Castleman's disease
Xiang-Gui Yuan1, Fei-Fei Chen, Yi-Miao Zhu
1The Second Affiliated Hospital, Binjiang Branch, School of Medicine, Zhejiang University, China.
Insights
Hepatitis B virus (HBV) infection is linked to Castleman
Area of Science:
- Hepatology
- Oncology
- Immunology
Background:
- Castleman's disease (CD) is a rare lymphoproliferative disorder with unknown causes.
- Hepatitis B virus (HBV) is prevalent in China, a region with a high incidence of CD.
Purpose of the Study:
- To investigate the association between HBV infection and Castleman's disease.
- To characterize clinical and pathological features of HBV-positive CD patients in China.
Main Methods:
- Retrospective analysis of 35 CD patients diagnosed over 10 years.
- Comparison of HBV prevalence in CD patients versus age/sex-matched healthy, national, and non-Hodgkin's lymphoma (NHL) controls.
- Analysis of clinicopathological characteristics and prognosis in HBV-positive versus HBV-negative CD patients.
Main Results:
- HBV infection prevalence in CD patients was 17.1%, significantly higher than healthy and national controls.
- HBV-positive CD patients showed a higher rate of malignant transformation to NHL (33.3%), increased splenomegaly (83.3%), and poorer prognosis.
Conclusions:
- Findings suggest a significant association between HBV infection and the development of Castleman's disease.
- HBV-positive CD patients present distinct clinical and pathological features and a worse prognosis.
Abstract:
Castleman's disease (CD) is a rare non-neoplastic lymphoproliferative disorder with ambiguous etiology. This study aimed to evaluate the potential association between hepatitis B virus (HBV) and CD and to characterize the HBV-positive CD patients in China, an endemic area for HBV infection. We compared the prevalence of HBV infection in 35 consecutive CD patients initially diagnosed in our hospitals over a 10-year period with an age- and sex-matched healthy control, a national population-based control, and a non-Hodgkin's lymphoma (NHL) control. We found that the prevalence of HBV infection in CD was 17.1% (6/35), which was as high as the NHL control (19.9%, P = 0.693), but significantly higher than the age- and sex-matched healthy control (6.9%, P = 0.033) and the national population-based control (7.2%, P = 0.037). Next, we compared the clinicopathological characteristics between HBV-positive and HBV-negative CD patients. We found that HBV-positive CD patients had a significantly higher NHL malignant transformation rate (33.3% vs. 0%, P = 0.025), higher splenomegaly rate (83.3% vs. 27.6%, P = 0.019), and much poorer prognosis (estimated mean overall survival time (50.83 vs. 64.34 months, P = 0.016). In conclusion, our findings suggest an association between HBV infection and development of CD. CD patients with HBV infection have their own distinguished features.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Retrovirus Life Cycles
Sexually Transmitted Infections
